Page last updated: 2024-10-28

hydralazine and Rheumatic Heart Disease

hydralazine has been researched along with Rheumatic Heart Disease in 3 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Rheumatic Heart Disease: Cardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
AITCHISON, JD1
CRANSTON, WI1
PRIEST, EA1
Artman, M1
Parrish, MD1
Graham, TP1
Serbin, VI1
Gasanova, AS1

Reviews

2 reviews available for hydralazine and Rheumatic Heart Disease

ArticleYear
Congestive heart failure in childhood and adolescence: recognition and management.
    American heart journal, 1983, Volume: 105, Issue:3

    Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Ele

1983
[Peripheral vasodilators in the treatment of heart failure].
    Pediatriia, 1982, Issue:1

    Topics: Cardiac Output; Cardiomyopathies; Coronary Circulation; Droperidol; Heart Failure; Humans; Hydralazi

1982

Other Studies

1 other study available for hydralazine and Rheumatic Heart Disease

ArticleYear
The effects of 1-hydrazinophthalazine on the pulmonary circulation in mitral disease.
    British heart journal, 1955, Volume: 17, Issue:4

    Topics: Disease; Heart Diseases; Heart Valve Diseases; Hydralazine; Lung; Mitral Valve; Pulmonary Circulatio

1955